EANS-Adhoc: november AG / Extraordinary Income From Extensive Debt Waiver

ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.


Today, november AG (ISIN: DE000A0Z24E9) succeeded in negotiating another waiver of a substantial loan. On the one hand, one of the major shareholders waives his entitlement to the repayment of a shareholder´s loan of approx. EUR 1.2 mio versus november AG without anything in return. On the other hand, also another loan to the subsidiary PROGEN Biotechnik GmbH in the amount of TEUR 670 is paid off completely by a one-off payment of TEUR 360.
Thus, short-term liabilities were reduced by a total of approx. EUR 1.9 mio. This loan waiver results in an extraordinary income of approx. EUR 1.5 mio, improving the equity base by this amount.

This constructive cooperation with the major shareholder represents another important milestone in the financial stabilization of the november AG and its subsidiaries.

end of announcement euro adhoc

issuer: november AG Hansaring 97 D-50670 Köln phone: +49(0)221-82005 20-10 FAX: +49(0)221-82005 20-15 mail: info@november.de WWW: http://www.november.de sector: Biotechnology ISIN: DE000A0Z24E9 indexes: CDAX, Prime All Share, Technology All Share

stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Stuttgart, Düsseldorf, Hannover, München
language: English

Digitale Pressemappe: http://www.ots.at/pressemappe/EASY_19995

Rückfragen & Kontakt:

Dr. Dirk Zurek
Tel.: +49 (0) 221 82200 520 10
E-Mail: ir@november.de